Author:
Ronacher Katharina,Chegou Novel N.,Kleynhans Léanie,Djoba Siawaya Joel F.,du Plessis Nelita,Loxton André G.,Maasdorp Elizna,Tromp Gerard,Kidd Martin,Stanley Kim,Kriel Magdalena,Menezes Angela,Gutschmidt Andrea,van der Spuy Gian D.,Warren Robin M.,Dietze Reynaldo,Okwera Alphonse,Thiel Bonnie,Belisle John T.,Cliff Jacqueline M.,Boom W. Henry,Johnson John L.,van Helden Paul D.,Dockrell Hazel M.,Walzl Gerhard
Funder
Bill and Melinda Gates Foundation
EDCTP
South African Technology for Human Resources and Industry Program
Case Western Reserve University
National Institute of Allergy and Infectious Diseases, National Institutes of Health
International Collaborations in Infectious Diseases Research
National Institute of Allergy and Infectious Diseases
South African government
South African Medical Research Council
Strategic Health Innovations Partnership
National Research Foundation
South African Research Chair Initiative: Biomarkers for TB
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference25 articles.
1. A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council;Hong Kong Chest Service/Tuberculosis Research Center Madras/British Medical Research;Am Rev Respir Dis,1981
2. A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis;Imperial;Nat Med,2018
3. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months;Mitchison;Am Rev Respir Dis,1993
4. Biomarkers for tuberculosis disease activity, cure, and relapse;Wallis;Lancet Infect Dis,2010
5. Month 2 culture status and treatment duration as predictors of tuberculosis relapse risk in a meta-regression model;Wallis;PLoS One,2013
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献